Answers are grounded in this paper and cite their sources.
Demonstrates sensitive DNA detection in clinical samples using cerium oxide nanosheets, indicating new biosensing potential.
Defect-engineered cerium oxide (CeO 2 ) nanosheets were developed as a label-free photoluminescence (PL) platform for ultrasensitive DNA detection. The CeO 2 nanosheets exhibited defect-mediated emission associated with oxygen vacancies. Probe DNA (ssDNA) immobilization enhanced PL intensity due to surface passivation, whereas hybridization with complementary target DNA (tDNA) induced significant PL quenching via guanine-mediated photoinduced electron transfer (PET). The biosensor showed a linear detection range of 0.35 to 42 pM with a low detection limit of 0.179 pM. Excellent selectivity and successful detection in clinical DNA samples demonstrate the potential of CeO 2 nanosheets for sensitive optical DNA biosensing.
No takes yet. Share an insight, caveat, or question.
Tigga et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: